PODD

Insulet Corporation

$148.13 +2.20%

Recent alerts on PODD

All signals →

News Medical device and healthcare services stocks lead sector's EPS revision rankings

News Stock index futures rise after tech rally lifts Nasdaq, S&P 500

News This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment

News Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5

News Insulet Peer Tandem Diabetes Underwhelming Earnings, Dull Outlook Drags Stock

News Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges

News Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer

News Why Insulet Stock Was Zooming Higher This Week

News Affirm, Mongodb And Best Buy Are Among Top 10 Large Cap Gainers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio?

News Thermo Fisher (TMO) Beats on Q2 Earnings, Raises 2024 EPS View - Zacks Investment Research

News Insulet's (PODD) Omnipod 5 Favored in Study for Type 2 Diabetes

News Insulet (PODD) Unveils Key Achievements for the Omnipod 5 System

News Stock index futures fall as hopes of a U.S.-Iran resolution fade

News Most healthcare companies report higher Y/Y EPS in strong earnings week

SEC filing PODD Reports $761.7M Revenue, $1.42 Adj. EPS, 33.9% YoY Growth, Raises FY Revenue Guidance

News FDA Flags High-Risk Recall Of Insulet's Omnipod 5 Pods Over Insulin Delivery Concerns

News Abbott is the most oversold healthcare stock as Q1 earnings roll on

News Notable healthcare headlines for the week: Organon, Eli Lilly, and Gilead in focus

News Insulet recalling certain defective Omnipod insulin delivery devices

Insider trade Purchase by Michael R Minogue

Insider trade Purchase by Ashley Mcevoy (President and CEO)

News Insulet outlines 21%–23% Omnipod revenue growth for 2026 with operating margin expansion, driven by global adoption and product innovation

News Insulet gains after Q4 print as outlook tops consensus

News Insulet Non-GAAP EPS of $1.55 beats by $0.09, revenue of $783.8M beats by $15.07M

SEC filing PODD Reports $2.7B Revenue, $3.48 EPS, +31% YoY, $350M Share Buyback Authorization

Get push alerts for PODD

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS